Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT07131618
Eligibility Criteria:
Inclusion Criteria:
* Applying to Mersin University Hospital Oncology Outpatient Clinic
* Willing to participate and providing signed informed consent
* Able to read and write in Turkish
* Accessible and able to communicate
* Citizen of the Republic of Türkiye
* Diagnosed with gynecologic cancer (ovarian, endometrial, or cervical) and aged ≥18 years
* Receiving weekly carboplatin + paclitaxel chemotherapy protocol
* No subjective peripheral neuropathy symptoms before starting chemotherapy
* No history of peripheral neuropathy related to previous taxane/platinum-based chemotherapy protocols
* No psychiatric disorders
* No diseases that may cause peripheral neuropathy such as diabetes, rheumatoid arthritis, or fibromyalgia
Exclusion Criteria:
* Not applying to the specified outpatient clinic
* No gynecologic cancer diagnosis or younger than 18 years old
* Not providing informed consent
* Not receiving weekly carboplatin + paclitaxel chemotherapy protocol
* Presence of subjective peripheral neuropathy symptoms before starting chemotherapy
* History of peripheral neuropathy related to previous taxane/platinum-based chemotherapy protocols
* Presence of psychiatric disorders
* Having diseases that may cause peripheral neuropathy such as diabetes, rheumatoid arthritis, or fibromyalgia
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07131618
Study Brief:
Protocol Section:
NCT07131618